Viewing Study NCT07213895


Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2026-02-04 @ 1:05 AM
Study NCT ID: NCT07213895
Status: COMPLETED
Last Update Posted: 2025-10-09
First Post: 2025-10-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tablets
Sponsor: Humanis Saglık Anonim Sirketi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus (T2DM) View
Keywords: